Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

4 Stocks To Watch: CRBP, CRR, NBIX, NBL

Published 01/04/2018, 12:28 AM
Updated 07/09/2023, 06:31 AM

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), which has the new swing trade I put on it on Tuesday, popped, and on Wednesday, it has a nice follow-through, up 55 cents, or 7%, to 8.50, on 2.4 million shares traded. If it can get above 8 3/4, then we‘re looking at a stock that can quickly run to 10 1/4, and then as much as 13 3/4-14.

CARBO Ceramics Inc. (NYSE:CRR) is looking very good. It had a beautiful base, breakout, then the wedge or coil formed. It looks like it moved up, tested the apex, and on Wednesday popped 71 cents, or 6.77%, to 11.19, on 868,644 shares traded. It closed right in the resistance range, but I’m thinking it has a move to 13-13 1/2, which is my next target.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX), the recent new swing I had when it broke out, has been moving for more than two days now, and followed through to my first target at 83 on Wednesday, jumping 3.68, or 4.64%, to 82.98, on 1.23 million shares traded. It’s been up for 5 days in a row, and 8 of the last 9 days. The follow-through should take it to 90.00.

Noble Energy, Inc. (NYSE:NBL) has a new swing that I put on it on Wednesday. I like this stock. Oil stocks, in general, are looking better. It formed a V-bottom, a platform, and then had a breakout, popping 82 cents, or 2.72%, to 31.01, on over 7 million shares traded on Wednesday. If it follows through, I would be looking for a move for it to get into the 35-6 zone, followed by 40-41.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the long side, stocks included Aurora Cannabis Inc. (OTC:ACBFF), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), BlackBerry Limited (NYSE:BB), General Cannabis Corp. (OTC:CANN), Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), California Resources Corporation (CRC), CARBO Ceramics Inc. (CRR), Galectin Therapeutics, Inc. (NASDAQ:GALT), GlycoMimetics, Inc. (NASDAQ:GLYC), INSYS Therapeutics, Inc. (NASDAQ:INSY), Kopin Corporation (NASDAQ:KOPN), Direxion Daily S&P Biotech Bull 3X ETF (NYSE:LABU), Remark Holdings, Inc. (NASDAQ:MARK), Mazor Robotics Ltd. (NASDAQ:MZOR), Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Noble Energy, Inc. (NYSE:NBL), NT Resources Ltd (NYSE:NTR), NvrsVIDIA Corporation (NASDAQ:NVDA), Overstock.com, Inc. (NASDAQ:OSTK), Renren Inc. (NYSE:RENN), Roku Inc (NASDAQ:ROKU), U.S. Silica Holdings, Inc. (NYSE:SLCA), Canopy Growth Corporation (OTC:TWMJF), Urogen Pharma Ltd. (NASDAQ:URGN), Viking Therapeutics, Inc. (NASDAQ:VKTX), 21Vianet Group, Inc. (NASDAQ:VNET), Valeant Pharmaceuticals (NYSE:VRX), Energous Corporation (NASDAQ:WATT), and W&T Offshore Inc. (NYSE:WTI).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.